Data Characteristics for This Category
Bispecific antibody product data primarily originates from preclinical research reports, clinical trial reports, patent literature, manufacturing process documents, and regulatory approval files. This data updates relatively infrequently, typically in stages based on research progress or regulatory requirements. Document structures are complex, containing extensive specialized terminology, biological pathway diagrams, pharmacokinetic (PK) data, pharmacodynamic (PD) data, safety data, and manufacturing batch information. Fields cover antibody sequences, targets, mechanisms of action, indications, routes of administration, dosages, adverse reactions, stability data, and quality control standards. Units are diverse, involving concentrations (nM, µg/mL), dosages (mg/kg), time (h, days), and affinity (Kd).
Constraints Imposed by These Characteristics on "Multi-Turn Conversations and Prompts"
The highly specialized and complex nature of bispecific antibody data requires multi-turn conversational systems to possess precise semantic understanding capabilities. This prevents misinterpretations of specialized terminology. The low update frequency means knowledge base construction must focus on data traceability and version management, ensuring cited information is the latest approved or published version. Complex document structures require the system to effectively extract key information from different sections, figures, and even appendices. For example, extracting half-life data from PK/PD reports, or identifying specific adverse event rates from safety reports. The diversity of fields and units places higher demands on prompt engineering. The system needs to accurately identify and use correct units when generating responses. For instance, distinguishing between mg/kg and µg/mL when answering dosage questions prevents information bias due to unit confusion. Additionally, multi-turn conversations may involve cross-document, cross-field logical reasoning, such as inferring potential combination therapy regimens by combining target information and mechanisms of action.
Configuration Settings
| Configuration Item | Recommended Value | Rationale for This Value |
|---|---|---|
maxContext | 8 | Ensures sufficient contextual information to support step-by-step explanations and follow-up questions for complex concepts. |
Recall count (Recall Count) | 15 | Antibody data is highly interconnected; increasing the recall count improves the coverage of relevant snippets. |
Similarity threshold (Similarity Threshold) | 0.78 | Raises the threshold to ensure recalled document snippets are highly relevant to the query, reducing interference. |
Chunk size (Segment Length) | 500 characters (characters) | Balances information completeness with single-segment processing efficiency, preventing key information from being truncated. |
Rerank result count (Reranked Return Count) | 5 | Selects the top few most relevant items, improving the quality and conciseness of the final answer. |
PARSE_FILE_TIMEOUT_SECONDS | 300 seconds (seconds) | Extends parsing time when processing large PDF reports to avoid failures due to timeouts. |
Three Common Pitfalls
- The conversation frequently displays "No relevant information found" or "Cannot answer" prompts, with logs showing a
similarity_scorethat is too low. This occurs because of an improper knowledge base segmentation strategy, leading to key information being cut off or lacking context, which prevents effective query matching. - When users ask about the dosage or administration regimen for a specific antibody, the system's response contains inaccurate units or values. For example,
mg/kgis mistakenly written asµg/mL. This happens because prompts do not explicitly require the model to focus on and validate unit information, or the knowledge base does not standardize units. - In multi-turn conversations, the system forgets or confuses antibody names or targets mentioned in previous turns. Responses become irrelevant to the current turn or drift off-topic. This is due to the
maxContextparameter being set too low, causing historical conversation information to be truncated and preventing long-term context maintenance.
How to Confirm Proper Configuration
- For core product information, such as mechanisms of action, indications, and dosages, conduct a series of questions including vague terms and synonyms. Check the accuracy and completeness of the system's responses and compare them against facts in the original documents.
- Design follow-up questions involving specialized terminology and complex logic, such as "How effective is this antibody when combined with an XX pathway inhibitor?". Check if the system can understand the context and provide reasonable inferences, and evaluate its understanding of specialized terminology.
- Upload multiple large clinical trial reports or patent documents. Test if the system can complete parsing within a reasonable time and accurately answer questions about key data points in the reports (e.g., efficacy rates, adverse event rates). Evaluate parsing efficiency and information extraction capabilities.
- Simulate a user repeatedly mentioning the same antibody or target across different turns. Observe if the system consistently maintains awareness of this core object, ensuring the
maxContextsetting effectively maintains conversational coherence.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.